Forma Life Science Marketing
Making the Complex Compelling
Commercial success in the life science and biotech industries demands careful and strategic positioning, clear articulation of benefits, and bridging the gap between the scientific and marketing approaches to communication.
For nearly 30 years, Forma Life Science Marketing has specialized in helping organizations of all sizes to hone in on their unique value to clarify their brand-story and differentiate their product and service offerings – all to increase sales and margins.
CEO and Co-founder David Chapin recently released his first book, Making the Complex Compelling: Creating High-Performance Marketing in the Life Sciences to give life science investors, researchers, founders, and marketers a logical and proven process to differentiate in a crowded and regulated marketplace.
Forma has particular expertise in:
- Using archetypes in B2B marketing to reach and engage target audiences
- Identifying and defining Enterprise Value Propositions to drive funding for growth and successful exit events
- Navigating brand and product families through M&As and divestures
- Enabling effective product and service launches and partnerships
Learn more. Visit formalifesciencemarketing.com or call 919.832.1244, x226.
“As a partner of Jones Day, a leading international law firm, I have been pleased to introduce the BioPontis Alliance for Rare Diseases to our firm for pro bono assistance, as I am extremely supportive of its mission and its unique approach in providing therapy development for rare disease patients. Assisting BioPontis provided Jones Day with a welcome path to continuing our Firm’s own efforts in support of societal programs of critical significance. In the case of BioPontis, we were honored to help, in our own small way, the millions of rare disease patients seeking treatment. Senior partner Howard Liebman and myself, as well as our team, are excited to have been part of the founding of the Brussels-based BioPontis Public Utility Foundation, and have been inspired by the passion which the Board and management of BioPontis brings to this important cause.” -Cristiana Spontoni
BioPontis Alliance recently announced the establishment of its Brussels, Belgium based Public Utility Foundation, providing a nonprofit footprint in the US and in Europe now. This critical step in preparing BioPontis to fulfill its mission of bringing new treatments for rare diseases forward, allows BioPontis to fundraise in Europe. It will provide for tax deductions for philanthropic support in Europe, once BioPontis has registered in the Transnational Giving Platform TGE, (active in 18 European Countries) as well as in the US through its recognition as a 501 (c) 3 charity. BioPontis is grateful to Jones Day in Brussels for the superb legal support and guidance it provided on a pro bono basis toward achieving this important milestone.
Bud Hayman Images, LLC.
Bud began his career in the United States as a professional videographer for QVC specializing in product, food and fashion… shot in studio, on location… and around the world. After living in Singapore, the commercial nerve center of the world, today his clients include healthcare, pharmaceuticals, restaurants – retail and film production companies. Bud brings more than just his skill to the job; his unsinkable happiness is infectious and he is known for respecting every aspect of the image making process.
Rob Tochterman is the owner of Neptune Productions, as well as a freelance video editor, director, graphic artist in the Philadelphia area. Neptune’s clients include Bristol-Myers Squibb, Johnson & Johnson, Bayer, Dow Chemical, Comcast SportsNet and numerous NYC & Philadelphia ad agencies. Neptune Productions has produced and edited everything from product demos, :30 and :60 TV spots, political ads, corporate training, meeting show openers, patient profile videos, web videos and documentaries, winning numerous industry awards including an Emmy, numerous Telly’s, and an Aurora award.